INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Patent Applications and Registrations

Patent applications and USPTO patent grants for INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM).The latest application filed is for "method of predicting whether a kidney transplant recipient is at risk of having allograft loss".

Company Profile

6.17.15

INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) - Paris FR
INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) - INSERM
Institute National de la Sante et de la Recherche Medicale-Inserm - Paris FR
Institute National de la Sante et de La Recherche Medicale-Inserm - Assistance Publique-Hopitaux De Paris

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Predicting Whether A Kidney Transplant Recipient Is At Risk Of Having Allograft Loss App 20220293274 - LOUPY; Alexandre ; et al.	2022-09-15
Method For The Modification Of A Device Surface By Grafting A Cd31-derived Peptide Onto The Surface Of Said Device App 20220001083 - NICOLETTI; Antonino ; et al.	2022-01-06
Compounds And Pharmaceutical Compositions For Reducing Cd95-mediated Cell Motility App 20210238143 - VACHER; Pierre ; et al.	2021-08-05
Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines Grant 11,046,657 - Bonnet , et al. June 29, 2	2021-06-29
Biomarker Of The Colour Perception Of A Mammal Subject Based On Pupil Frequency Tagging App 20210076931 - POUGET; Pierre ; et al.	2021-03-18
Ion Channel Inhibitor Compounds For Cancer Treatment App 20210009581 - ROUTIER; Sylvain ; et al.	2021-01-14
Use of gingival fibroblasts in the treatment of alopecia App 20200306174 - LAFONT; Antoine ; et al.	2020-10-01
Use Of Phenothiazine Derivative In The Treatment Of Infection Caused By Bacteria Carrying Type Iv Pili App 20200222418A1 -	2020-07-16
Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer App 20200081009 - Muller; Catherine ; et al.	2020-03-12
Antiviral Compositions For The Treatment Of Infections Linked To Coronaviruses App 20190307722 - ROSA-CALATRAVA; Manuel ; et al.	2019-10-10
Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer Grant 10,401,365 - Muller , et al. Sep	2019-09-03
Device And System For Generating Ultrasonic Waves In A Target Region Of A Soft Solid And Method For Locally Treating A Tissue App 20180317884 - CHAPELON; Jean-Yves ; et al.	2018-11-08
Treatment of cancer by inhibition of the MYD88/ERK MAP kinase interaction Grant 9,683,986 - Kfoury , et al. June 20, 2	2017-06-20
Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer App 20170131282 - Muller; Catherine ; et al.	2017-05-11
Optical System Comprising A Spatial Light Modulator App 20170017076 - Guillon; Marc ; et al.	2017-01-19
Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in the KIAA1840 gene or protein Grant 9,546,402 - Azzedine , et al. January 17, 2	2017-01-17
TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms Grant 9,389,233 - Viguie , et al. July 12, 2	2016-07-12
Method of treating an ocular pathology by applying ultrasound to the trabecular meshwork and device thereof Grant 9,259,597 - Romano , et al. February 16, 2	2016-02-16
Methods for the treatment and the diagnosis of cancer Grant 8,933,050 - Friedlander , et al. January 13, 2	2015-01-13
Production Of A Human Beta Cell Line From An Early Post Natal Pancreas App 20140302155 - Czernichow; Paul ; et al.	2014-10-09
Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging Grant 8,709,383 - Scherman , et al. April 29, 2	2014-04-29
Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseases Grant 8,679,500 - Boumsell , et al. March 25, 2	2014-03-25
Composition for the treatment of atherosclerosis Grant 8,324,152 - Tedgui , et al. December 4, 2	2012-12-04
Derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same Grant 7,582,797 - Roques , et al. September 1, 2	2009-09-01
Non-M, non-O HIV-1 strains, fragments and uses Grant 7,534,877 - Mauclere , et al. May 19, 2	2009-05-19
Non-M, non-O HIV-1 strains, fragments and uses App 20070190524 - Mauclere; Phillippe ; et al.	2007-08-16
Non-M, non-O HIV-1 strains, fragments and uses Grant 7,030,234 - Mauclere , et al. April 18, 2	2006-04-18
Method for inhibiting fibrogenesis Grant 6,649,615 - Dubuisson , et al. November 18, 2	2003-11-18
LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications Grant 6,635,431 - Bihain , et al. October 21, 2	2003-10-21
Non-M, non-O HIV-1 strains, fragments and uses App 20030157660 - Mauclere, Phillippe ; et al.	2003-08-21
Diagnosis of glaucoma App 20030068632 - Garchon, Henri-Jean	2003-04-10
Process for determining the quantity of a DNA fragment of interest by a method of enzymatic amplification of DNA Grant 5,747,246 - Pannetier , et al. May 5, 1	1998-05-05
Uncrosslinked hydrogel, process for its preparation and its uses as an article for medical and/or surgical purposes such as tubes, films, joints, implants and the like, particularly in ophthalmology Grant 5,273,750 - Homiger , et al. December 28, 1	1993-12-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.